I can appreciate your pessimism, OJ. It’s difficult to see a path back to $2. However, the NGIO valuation could get us there. The incessant delays in the dividends have dampened everyone’s enthusiasm. If MMPJoe can deliver on the dividends and NGIO gets a favorable valuation, maybe NASDAQ listing will follow.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links